Access links:
CONTENT
Destacados
HIV immunopathogenesis and vaccines
Publications
-
A cell-to-cell HIV transfer assay identifies humoral responses with broad neutralization activity
Vaccine. 2011 Jul 18;29(32):5250-9. doi: 10.1016/j.vaccine.2011.05.016. Epub 2011 May 24
BACKGROUND: Cell-to-cell HIV spread through virological synapses proceeds in two steps, first HIV particles are rapidly...
-
The reconstitution of the thymus in immunosuppressed individuals restores CD4-specific cellular and...
Immunology. 2011 Jul;133(3):318-28. doi: 10.1111/j.1365-2567.2011.03442.x. Epub 2011 Apr 19.
Infection with HIV-1 frequently results in the loss of specific cellular immune responses and an associated lack of antibodies....
-
The Magnitude of Interferon-gamma. Responses to Human Cytomegalovirus is predictive for HIV-1...
J Acquir Immune Defic Syndr 2008 00, 000-000
Background: Human cytomegalovirus (HCMV) infection has been strongly associated to HIV-1 progression. We have...
-
Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after...
Immunology 126, 386-393.
The interferon (IFN)-gamma component of the immune response plays an essential role in combating infectious and non-infectious...
Seminars and Congresses
AIDS Vaccine 2013 - BARCELONA
07.10.13bb AIDS Vaccine is the largest and most diverse international meeting of researchers, advocates, clinicians, private sector partners and...
- 19.03.13 - 19.03.13
[IrsiCaixa Seminar] Will it be possible to live without cART? Natural and induced control of HIV-infection
IrsiCaixa Seminar: Will it be possible to live without cART? Natural and induced control of HIV-infection
Lecturer: Asier Sáez-Cirión.
More information - 11.03.13 - 11.03.13
POST-CROI 2013: 20th Conference on Retroviruses and Opportunistic Infections Update
When: March 11th 2013. 2.30pm
Where: Auditori de La Pedrera. Passeig de Gràcia, 92. Barcelona
Projects
Impacto de la infección por el VIH sobre la acción de la IL-12 y IL-18 sobre monolitos y macrófagos: relevancia...
Financing entity: Ministerio de Sanidad
Participant entities: Fundació IrsiCaixa
